Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Hicks

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
MLO: Medical Laboratory Observer|February 23, 2012
Targeted therapies in breast cancer: tailoring treatment to the molecular drivers of disease progressionDavid G Hicks
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 18, 2011
Immunohistochemistry in the diagnostic evaluation of breast lesionsDavid G Hicks
AORN Journal|May 31, 2014
Standardization of tissue handling from the OR to the laboratoryDavid G Hicks
The Breast Journal|August 18, 2012
Breast and Prostate Cancer in a BRCA2 CarrierTara Mahar, David G Hicks
Annals of Surgical Oncology|April 10, 2008
HER2-positive early breast cancer and trastuzumab: a surgeon's perspectiveSwati Kulkarni, David G Hicks
American Journal of Clinical Pathology|January 23, 2008
HER2+ breast cancer: review of biologic relevance and optimal use of diagnostic toolsDavid G Hicks, Swati Kulkarni
Archives of Pathology & Laboratory Medicine|June 4, 2008
Trastuzumab as adjuvant therapy for early breast cancer: the importance of accurate human epidermal growth factor receptor 2 testingDavid G Hicks, Swati Kulkarni
JAMA|October 21, 2004
HER-2 testing in breast cancerRaymond R Tubbs, David G Hicks
Archives of Pathology & Laboratory Medicine|July 1, 2014
Progress in implementing HER2 testing guidelinesPatrick L Fitzgibbons, David G Hicks
Archives of Pathology & Laboratory Medicine|June 3, 2011
Citius, altius, fortius-self-assessment in pathology and laboratory medicine: College of American Pathologists Self-assessment Module CommitteeJames S Hernandez, David G Hicks
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
MLO: Medical Laboratory Observer|February 23, 2012
Targeted therapies in breast cancer: tailoring treatment to the molecular drivers of disease progressionDavid G Hicks
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 18, 2011
Immunohistochemistry in the diagnostic evaluation of breast lesionsDavid G Hicks
AORN Journal|May 31, 2014
Standardization of tissue handling from the OR to the laboratoryDavid G Hicks
The Breast Journal|August 18, 2012
Breast and Prostate Cancer in a BRCA2 CarrierTara Mahar, David G Hicks
Annals of Surgical Oncology|April 10, 2008
HER2-positive early breast cancer and trastuzumab: a surgeon's perspectiveSwati Kulkarni, David G Hicks
American Journal of Clinical Pathology|January 23, 2008
HER2+ breast cancer: review of biologic relevance and optimal use of diagnostic toolsDavid G Hicks, Swati Kulkarni
Archives of Pathology & Laboratory Medicine|June 4, 2008
Trastuzumab as adjuvant therapy for early breast cancer: the importance of accurate human epidermal growth factor receptor 2 testingDavid G Hicks, Swati Kulkarni
JAMA|October 21, 2004
HER-2 testing in breast cancerRaymond R Tubbs, David G Hicks
Archives of Pathology & Laboratory Medicine|July 1, 2014
Progress in implementing HER2 testing guidelinesPatrick L Fitzgibbons, David G Hicks
Archives of Pathology & Laboratory Medicine|June 3, 2011
Citius, altius, fortius-self-assessment in pathology and laboratory medicine: College of American Pathologists Self-assessment Module CommitteeJames S Hernandez, David G Hicks
Pageof 14